Prostate cancer is the second leading cause of cancer death among American men. About 30,000 men die and 240,000 are diagnosed every year. Most of these men, however, are more likely to die with prostate cancer, rather than from it.
Because of these statistics, thoughts on treatment are beginning to change. Some are of the opinion that treatment is far too aggressive and others say that treatment isn't aggressive enough. Deciding the best course of treatment can be tricky though, as everyone's cancer is a little different. Based on cell proliferation, two men in the same stage of prostate cancer could have entirely different mortality rates and therefore need completely different treatments. The Polaris Test can help provide the answers physicians need to determine that. The test identifies how fast the cancer cells are replicating and combines cell cycle gene expression with standard clinicopathologic parameters.
Take a look at this infographic for more on how the Polaris test could revolutionize prostate cancer treatment.